Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.455 USD | -4.09% | -14.05% | -42.62% |
Evolution of the average Target Price on Altimmune, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Altimmune, Inc.
Guggenheim | |
B. Riley | |
HC Wainwright | |
Goldman Sachs | |
Evercore ISI | |
JMP Securities | |
Jefferies & Co. | |
Piper Sandler |
EPS Revisions
- Stock Market
- Equities
- ALT Stock
- Consensus Altimmune, Inc.